Malignant Hem Debates “Back to the future: should we be using gemtuzumab ozogamycin in induction therapy for AML?” David Rizzieri, MD, Professor vs Thomas Leblanc, MD, Associate Professor “DLBCL front line treatment--dinosaurs can be CHOPped but are we